3D maps of diseased tissues at subcellular precision

An open-source platform developed by researchers in Nikolaus Rajewsky’s lab at the Max Delbrück Center creates molecular maps from patient tissue samples with subcellular precision, enabling detailed study and potentially enhancing routine clinical…

3 Min
More

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism

Pentixapharm AG, a radiopharmaceutical development company wholly owned by Eckert & Ziegler SE, today announced that it has received encouraging feedback from the U.S. Food and Drug Administration (FDA) following a recent Type C meeting with the…

3 Min
More

Berlin Center for Gene and Cell Therapies kicked off in Berlin

Berlin Center for Gene and Cell Therapies aspires to create a leading biotech ecosystem in Berlin / Federal Chancellor Scholz acknowledges the importance of the project for Germany / Governing Mayor of Berlin Kai Wegner assures support from the State…

9 Min
More

Novel Cancer Therapeutic from FMP Research enters clinical phase

Groundbreaking innovations by researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) provided the basis for the development of an antibody-drug conjugate (ADC) by the company Tubulis, which is now being used in a Phase I/IIa…

2 Min
More

MSD launches IDEA Studios in Berlin

IDEA Studios will be strategically located in Asian and European innovation hubs to partner closely with early-stage companies focused on improving patient care

5 Min
More

In severe COVID-19, neutrophils work overtime

Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns…

4 Min
More

New perspectives for patients: National Strategy for Gene and Cell Therapies presented to the BMBF

Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the…

5 Min
More

Interview | Uirá Souto Melo, PhD CEO and Co-Founder of Lucid Genomics

„Berlin is the best place for AI startups in Germany”

4 Min
More

Tacalyx extends Seed Round to over €14 M to Advance Development of its Cancer Therapeutics Targeting TACAs

BERLIN, Germany, June 11, 2024 – Tacalyx, a privately held biotech company focused on developing novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announces the extension of its seed financing to over €14 M. This extension…

3 Min
More

QS World University Rankings 2025: Freie Universität Berlin Places Fourth among German Universities

University ranks ninety-seventh in the world. According to this year’s QS World University Rankings, Freie Universität Berlin is among the top four universities in Germany. The rankings are published annually by higher education consulting firm…

1 Min
More
Show more items